Navigation Links
'Stereo' Mammography Takes Breast Imaging to a New Dimension
Date:11/28/2007

indings were detected by the combined mammography procedures and were referred for additional diagnostic testing, including biopsy when indicated. Of those, 109 were determined to be true lesions. Standard mammography missed 40 of the 109 lesions while the stereoscopic exam failed to detect 24.

"Our early results suggest that stereo digital mammography could contribute to the earlier detection of cancer," Dr. Getty said. "A small percentage of the additional lesions missed by standard mammography but detected by stereoscopic mammography will turn out to be cancerous."

Of the 259 findings, 150 were false positives, meaning further testing revealed that no abnormality was present. Standard mammography yielded 103 false positives; stereo mammography yielded 53.

"In our study, stereo digital mammography reduced false positives by 49 percent," said Dr. Getty. "This could have a significant impact by cutting in half the number of women who are needlessly recalled for additional diagnostic work-ups, resulting in a large savings in cost and patient anxiety."

By the end of the clinical trial this December, a total of 1,500 women at elevated risk of developing breast cancer will have received both the stereo and standard digital mammography screening exams.

According to Dr. Getty, offering wide-scale stereoscopic digital mammography would entail minor changes to digital mammography equipment and software.

Co-authors of the paper are C.J. D'Orsi, M.D., R.M. Pickett, Ph.D., M.S. Newell, M.D., K.R. Gundry, M.D., S.F. Roberson, M.D., S.R. Bates, M.D., et al.

Dr. Getty is employed by BBN Technologies. BBN Technologies and Planar Systems developed the stereo display workstation used in the trial.

AT A GLANCE

-- A new mammography technology allows radiologists to detect more cancers

with fewer false positives.

-- Stereoscopic digital mammography produces three-dimensional, in-depth

views of
'/>"/>

SOURCE Radiological Society of North America
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
2. VA National Campaign Takes Aim at Resistant Staph Infections
3. Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
7. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
8. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
9. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
10. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
11. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sony Biotechnology Inc. ("Sony") today announced the launch of ... be exhibiting and taking orders for this system at ... San Diego Convention Center in ... - 22.  The SP6800 Spectral Analyzer ... into new and novel functionalities for the immunology, oncology, ...
(Date:5/17/2013)...  TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... 11, 2007 /PRNewswire-FirstCall/ - Paul S.,Aisen, M.D., ... Medical Center, and principal investigator in the ... III clinical trial,for tramiprosate (ALZHEMED(TM)) will present ... for the treatment of,Alzheimer's disease (AD). The ...
... /PRNewswire/ -- Sugammadex -,the novel selective relaxant binding ... business unit of Akzo Nobel -,demonstrated in a ... of neuromuscular blockade as compared to neostigmine,without evidence ... muscle relaxation.(1),(2) The results of this,pivotal Aurora trial ...
Cached Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 3Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 4
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
(Date:5/20/2013)... InVite® Health, a leading nutraceutical firm ... of its new Greens Hx™ product; a ... with plant extracts from 39 super foods including sea ... pectin, plant enzymes and non-dairy probiotics. A small ... levels of several servings of vegetables. The product is ...
(Date:5/20/2013)... May 20, 2013 The transvaginal mesh ... device law firm, report that two important bellwether trials ... in state and federal litigations established for C.R. Bard ... the first C.R. Bard bellwether trial will begin in ... of West Virginia. (In re: C.R. Bard, Inc., ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Today is ... Perfect Interview Answers Webinar tomorrow. Job seekers ... Career Confindential’s expert career coach, will show job seekers ... Webinar attendees will also learn the perfect interview answers ... as interview techniques that will get them hired. Job ...
(Date:5/19/2013)... California has one of the largest pool of ... discovering that comprehensive background checks are playing an important role ... Driving records can paint an accurate portrait of a ... any DUI arrests, speeding offenses, and traffic violations to their ... to experience 4SafeDrivers.com, a new online service which allows users ...
Breaking Medicine News(10 mins):Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential 2Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2
... ANN ARBOR, Mich.---Apparently your mom had it right when she ... talked dirty. Lying really does create a desire to clean ... study. "The references to ,dirty hands, or ,dirty mouths, ... of moral purity in terms of more concrete experiences with ...
... at the Indiana University Melvin and Bren Simon Cancer ... show that changes in brain tissue can occur in ... of chemotherapy, often referred to as "chemobrain," have been ... the first to use brain imaging to study women ...
... , CHAPEL HILL, N.C. -- A team of UNC ... National Cancer Institute,s Cancer Nanotechnology Platform Partnerships to address ... effective treatments for pancreatic cancer. Wenbin Lin, PhD, ... MD, assistant professor of surgery and pharmacology, are the ...
... between the increase in sales of new antidepressants in recent ... a study based on figures from the Nordic countries, researchers ... that increased sales of the new medicines could be linked ... find any relationship between reduced sales of the older and ...
... UN Millennium Development Goals (MDG) summit in New York ... the eight goals agreed in 2000 on alleviating world ... to a close, governments, businesses and aid organisations made ... emphasis on improving maternal and child health. A global ...
... Reporter , TUESDAY, Sept. 28 (HealthDay News) -- Think recess, ... break in the school day set aside for running and ... adult life. What if your workplace started offering recess on ... a good idea but possibly one of the most solid ...
Cached Medicine News:Health News:Dirty hands, dirty mouths: U-M study finds a need to clean the body part that lies 2Health News:IU researchers: Chemotherapy alters brain tissue in breast cancer patients 2Health News:Decrease in suicide not linked to newer antidepressants 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4
The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
Used to negotiate tortuous vessels....
The Emerald Guidewire is intended for percutaneous introduction of catheters....
... The MULTI-LINK VISION Coronary Stent System is ... cobalt chromium stents. Cobalt chromium is stronger ... a cobalt chromium stent can have similar ... steel stent with struts that are only ...
Medicine Products: